TELMISARTAN Mepha cpr 80 mg 30 pce
7680629210115
CH-62921
C09CA07
02.07.1.
1 / 2
google
Details
- Product number
- 6292102
- CPT
- -
- Packaging group
- 30
- Unit
- Tablette(n)
- Composition
- telmisartanum 80 mg, natrii hydroxidum corresp. natrium 5.35 mg, hypromellosum, sorbitolum 38.40 mg, povidonum K 90, megluminum, mannitolum, magnesii stearas, pro compresso.
Articles (1)
Telmisartan-Mepha 80 mg, Tabletten
Tabletten
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
80.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
5.35 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
38.4 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 35.00
Specialties list
Yes
Generic
Yes
SL addition date:
01/03/2021
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 62921
- Drug name
- Telmisartan-Mepha, Tabletten
- Galenic form
- TAB
- ATC Code
- C09CA07
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 23/01/2014
- Authorization expiration date
- 31/12/9999
- IT number
- 02.07.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TELMISARTAN Mepha cpr 80 mg 30 pce
- Description (DE)
- TELMISARTAN Mepha Tabl 80 mg 30 Stk
- Market launch
- 23/01/2014
- Narcotic (BTM)
- No